Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease

Neurology. 1999 Oct 22;53(7):1605-6. doi: 10.1212/wnl.53.7.1605.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Dopamine Antagonists / adverse effects
  • Dopamine Antagonists / therapeutic use*
  • Female
  • Humans
  • Huntington Disease / drug therapy*
  • Huntington Disease / physiopathology
  • Middle Aged
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Dopamine Antagonists
  • Piperidines
  • OSU 6162